Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ANALYTICAL
ABOUT THIS PAGE
61
PharmaCompass offers a list of Agomelatine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Agomelatine manufacturer or Agomelatine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Agomelatine manufacturer or Agomelatine supplier.
PharmaCompass also assists you with knowing the Agomelatine API Price utilized in the formulation of products. Agomelatine API Price is not always fixed or binding as the Agomelatine Price is obtained through a variety of data sources. The Agomelatine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide, including repackagers and relabelers. The FDA regulates N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide supplier is an individual or a company that provides N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide active pharmaceutical ingredient (API) or N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide finished formulations upon request. The N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide suppliers may include N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide API manufacturers, exporters, distributors and traders.
click here to find a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide DMF (Drug Master File) is a document detailing the whole manufacturing process of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide active pharmaceutical ingredient (API) in detail. Different forms of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide DMFs exist exist since differing nations have different regulations, such as N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide DMF submitted to regulatory agencies in the US is known as a USDMF. N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide USDMF includes data on N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide Drug Master File in Korea (N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide. The MFDS reviews the N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide KDMF as part of the drug registration process and uses the information provided in the N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide KDMF to evaluate the safety and efficacy of the drug.
After submitting a N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide API can apply through the Korea Drug Master File (KDMF).
click here to find a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide suppliers with KDMF on PharmaCompass.
A N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide written confirmation (N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide WC) is an official document issued by a regulatory agency to a N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide manufacturer, verifying that the manufacturing facility of a N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide APIs or N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide finished pharmaceutical products to another nation, regulatory agencies frequently require a N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide WC (written confirmation) as part of the regulatory process.
click here to find a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide suppliers with NDC on PharmaCompass.
N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide GMP manufacturer or N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide GMP API supplier for your needs.
A N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide CoA (Certificate of Analysis) is a formal document that attests to N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide's compliance with N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide specifications and serves as a tool for batch-level quality control.
N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide CoA mostly includes findings from lab analyses of a specific batch. For each N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide may be tested according to a variety of international standards, such as European Pharmacopoeia (N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide EP), N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide USP).
